

香港微科生物技術有限公司榮獲Hong Kong Economic Times (HKCT) 頒發「年度最傑出生物技術產品」獎項,香港微科行政總裁James Chan 應邀出席領獎禮並上台接受獎項。
過去一年,香港微科團隊一直透過專業知識,為客戶提供全面的顧客服務及最先進的生物技術產品。能夠獲得外界嘉許和認可,會成為我們新一年繼續努力的原動力。
香港微科生物技術有限公司榮獲Hong Kong Economic Times (HKCT) 頒發「年度最傑出生物技術產品」獎項,香港微科行政總裁James Chan 應邀出席領獎禮並上台接受獎項。
過去一年,香港微科團隊一直透過專業知識,為客戶提供全面的顧客服務及最先進的生物技術產品。能夠獲得外界嘉許和認可,會成為我們新一年繼續努力的原動力。
Other news
亞洲最有價值品牌大獎2024
Hong Kong Weike Biotechnology Company Limited was awarded “Most Trusted Biotechnology Solutions Of The Year” of Asia’s
九月
Scientific Annual Report of CELLBANKERs (2023)
・ The number of citations in 2023 was 266 and reached record high. ・The number of
五月
2023年度最傑出生物技術產品
Hong Kong Weike Biotechnology Company Limited was awarded「年度最傑出生物技術產品」of the HKCT Business Awards 2023 held by
九月
Global Cell Freezing Media for Cell Therapy Professional Survey Report
A report titled, “Global Cell Freezing Media for Cell Therapy Professional Survey Report 2022, Forecast
四月
CELLBANKER’s Scientific Annual Report (2021)
ZENOAQ has issued publications on research of cell cryopreserved regularly. Here is the summary for
二月